Caribou Biosciences Inc. (NASDAQ: CRBU) closed the day trading at $5.26 down -10.32% from the previous closing price of $5.86. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 2063848 shares were traded. CRBU stock price reached its highest trading level at $5.75 during the session, while it also had its lowest trading level at $5.25.
For a better understanding of CRBU, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.80 and its Current Ratio is at 7.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on July 11, 2023, initiated with a Buy rating and assigned the stock a target price of $23.
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 19 when Rizvi Syed Ali-aamir sold 5,627 shares for $6.31 per share. The transaction valued at 35,506 led to the insider holds 59,373 shares of the business.
Fischesser Ryan sold 10,000 shares of CRBU for $107,958 on Oct 06. The VP of Finance and Controller now owns 110,366 shares after completing the transaction at $10.80 per share.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 517.35M and an Enterprise Value of 285.35M. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.28 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 20.02 whereas that against EBITDA is -2.40.
Stock Price History:
Over the past 52 weeks, CRBU has reached a high of $12.40, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is 6.49, while the 200-Day Moving Average is calculated to be 5.90.
Over the past 3-months, CRBU traded about 3.59M shares per day on average, while over the past 10 days, CRBU traded about 2.91M shares per day. A total of 88.28M shares are outstanding, with a floating share count of 77.29M. Insiders hold about 1.30% of the company’s shares, while institutions hold 72.10% stake in the company. Shares short for CRBU as of Aug 30, 2023 were 6.79M with a Short Ratio of 6.79M, compared to 7.29M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.69% and a Short% of Float of 8.07%.
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$0.42 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.53, while EPS last year was -$0.44. The consensus estimate for the next quarter is -$0.34, with high estimates of $0 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.11 and -$1.94 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.86, with 7 analysts recommending between -$1.69 and -$2.29.
For the next quarter, 5 analysts are estimating revenue of $9.73M, an increase of 163.50% over than the figure of -$5.50% in the same quarter last year. There is a high estimate of $32.7M for the next quarter, whereas the lowest estimate is $3M.
A total of 7 analysts have provided revenue estimates for CRBU’s current fiscal year. The highest revenue estimate was $40M, while the lowest revenue estimate was $13.26M, resulting in an average revenue estimate of $18.72M. In the same quarter a year ago, actual revenue was $13.85M, up 35.20% from the average estimate.